Avant

Avant Bio is a private early-stage and growth equity investment firm focused on life sciences, TechBio, healthtech, diagnostics, and therapeutic enabling technologies. Rather than developing its own drug pipeline, the firm backs companies working at the intersection of biology and advanced technology, including biomanufacturing tools, automation, machine learning, and AI applications for healthcare. The company positions itself around enabling next-generation therapeutic development and scaling the infrastructure behind modern biotech innovation. Avant Bio appears to be an active, women-founded firm headquartered in New York and led by founder Daniella Kranjac.